A Trial to Evaluate the Efficacy and Safety of Ninerafaxstat in Patients With Symptomatic Non-obstructive Hypertrophic Cardiomyopathy
Public ClinicalTrials.gov record NCT07023614. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Global Phase 2b, Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of Ninerafaxstat in Patients With Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy - FORTITUDE-HCM
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
FORTITUDE-HCM is a global, multicenter, double-blind, parallel-group, placebo-controlled Phase 2b study that will assess the efficacy and safety of ninerafaxstat compared to placebo on top of Standard of Care in patients with symptomatic nHCM
Study identification
- NCT ID
- NCT07023614
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 165 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 6, 2025 (Actual)
- Primary completion
- Dec 2026 (Estimated)
- Completion
- Dec 2026 (Estimated)
- Last update posted
- Oct 26, 2026
2025 – 2026
United States locations
- U.S. sites
- 26
- U.S. states
- 18
- U.S. cities
- 24
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Imbria Investigational Site | La Jolla | California | 92037 | Recruiting |
| Imbria Investigational Site | Los Angeles | California | 90048 | Recruiting |
| Imbria Investigational Site | San Francisco | California | 94143 | Recruiting |
| Imbria Investigational Site | Washington D.C. | District of Columbia | 20010 | Recruiting |
| Imbria Investigational Site | Miami | Florida | 33136 | Recruiting |
| Imbria Investigational Site | Atlanta | Georgia | 30322 | Not yet recruiting |
| Imbria Investigational Site | Chicago | Illinois | 60611 | Recruiting |
| Imbria Investigational Site | Oak Lawn | Illinois | 60453 | Not yet recruiting |
| Imbria Investigational Site | Baltimore | Maryland | 21218 | Recruiting |
| Imbria Investigational Site | Boston | Massachusetts | 02114 | Recruiting |
| Imbria Investigational Site | Burlington | Massachusetts | 01805 | Recruiting |
| Imbria Investigational Site | Grand Rapids | Michigan | 49503 | Recruiting |
| Imbria Investigational Site | Rochester | Minnesota | 55905 | Recruiting |
| Imbria Investigational Site | St Louis | Missouri | 63110 | Recruiting |
| Imbria Investigational Site | New York | New York | 10016 | Recruiting |
| Imbria Investigational Site | New York | New York | 10032 | Not yet recruiting |
| Imbria Investigational Site | Charlotte | North Carolina | 28204 | Recruiting |
| Imbria Investigational Site | Portland | Oregon | 97239 | Recruiting |
| Imbria Investigational Site | Philadelphia | Pennsylvania | 19104 | Recruiting |
| Imbria Investigational Site | Philadelphia | Pennsylvania | 19107 | Recruiting |
| Imbria Investigational Site | Houston | Texas | 77030 | Not yet recruiting |
| Imbria Investigational Site | Plano | Texas | 75093 | Recruiting |
| Imbria Investigational Site | Salt Lake City | Utah | 84132-0001 | Not yet recruiting |
| Imbria Investigational Site | Charlottesville | Virginia | 22903 | Recruiting |
| Imbria Investigational Site | Richmond | Virginia | 23298 | Recruiting |
| Imbria Investigational Site | Milwaukee | Wisconsin | 53215 | Not yet recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 49 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07023614, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 26, 2026 · Synced Oct 27, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT07023614 live on ClinicalTrials.gov.